Medline Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	1,939	199	1,556
Cash & Short-Term Investments	1,939	199	1,556
Cash Growth	874.37%	-87.21%	-
Accounts Receivable	3,533	3,219	2,960
Inventory	4,769	4,456	3,813
Other Current Assets	438	398	480
Total Current Assets	10,679	8,272	8,809
Net Property, Plant & Equipment	4,778	4,595	4,501
Other Intangible Assets	13,893	14,559	14,788
Goodwill	8,079	8,065	7,532
Other Long-Term Assets	1,055	487	492
Total Assets	38,484	35,978	36,122
Accounts Payable	961	869	696
Accrued Expenses	1,452	1,493	1,351
Current Portion of Long-Term Debt	77	78	75
Other Current Liabilities	-	-	9
Total Current Liabilities	2,490	2,440	2,131
Long-Term Debt	12,484	16,416	16,442
Other Long-Term Liabilities	4,224	598	572
Total Long-Term Liabilities	16,708	17,014	17,014
Total Liabilities	19,198	19,454	19,145
Common Stock	-	-	16,556
Additional Paid-in Capital	10,717	-	-
Accumulated Other Comprehensive Income	27	11	188
Retained Earnings	-7	16,147	-
Total Common Shareholders' Equity	10,737	16,158	16,744
Minority Interest	8,549	366	233
Shareholders' Equity	19,286	16,524	16,977
Total Liabilities & Equity	38,484	35,978	36,122
Total Debt	12,561	16,494	16,517
Net Cash (Debt)	-10,622	-16,295	-14,961
Net Cash Per Share	-13.11	-	-
Book Value	10,737	16,158	16,744
Book Value Per Share	13.26	-	-
Tangible Book Value	-11,235	-6,466	-5,576
Tangible Book Value Per Share	-13.87	-	-

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q